kr137.10
0.29% day before yesterday
Stockholm, Oct 03, 05:29 pm CET
ISIN
SE0011205202
Symbol
VITR

Vitrolife Target price 2025 - Analyst rating & recommendation

Vitrolife Classifications & Recommendation:

Buy
80%
Hold
20%

Vitrolife Price Target

Target Price kr173.40
Price kr137.10
Potential
Number of Estimates 7
7 Analysts have issued a price target Vitrolife 2026 . The average Vitrolife target price is kr173.40. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 8 Analysts recommend Vitrolife to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Vitrolife stock has an average upside potential 2026 of . Most analysts recommend the Vitrolife stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion kr 3.61 3.57
2.76% 1.11%
EBITDA Margin 29.26% 30.34%
5.18% 3.69%
Net Margin 14.21% 12.28%
112.96% 13.61%

7 Analysts have issued a sales forecast Vitrolife 2025 . The average Vitrolife sales estimate is

kr3.6b
Unlock
. This is
0.85% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
kr3.7b 4.01%
Unlock
, the lowest is
kr3.4b 3.65%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 kr3.6b 2.76%
2025
kr3.6b 1.11%
Unlock
2026
kr3.8b 6.81%
Unlock
2027
kr4.1b 8.42%
Unlock
2028
kr4.4b 6.92%
Unlock

7 Analysts have issued an Vitrolife EBITDA forecast 2025. The average Vitrolife EBITDA estimate is

kr1.1b
Unlock
. This is
14.48% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
kr1.1b 20.19%
Unlock
, the lowest is
kr1.0b 7.29%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 kr1.1b 8.09%
2025
kr1.1b 2.56%
Unlock
2026
kr1.2b 12.93%
Unlock
2027
kr1.4b 11.94%
Unlock
2028
kr1.4b 5.11%
Unlock

EBITDA Margin

2024 29.26% 5.18%
2025
30.34% 3.69%
Unlock
2026
32.08% 5.74%
Unlock
2027
33.12% 3.24%
Unlock
2028
32.56% 1.69%
Unlock

7 Vitrolife Analysts have issued a net profit forecast 2025. The average Vitrolife net profit estimate is

kr438m
Unlock
. This is
3.69% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
kr488m 7.19%
Unlock
, the lowest is
kr345m 24.16%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 kr513m 113.32%
2025
kr438m 14.58%
Unlock
2026
kr547m 24.90%
Unlock
2027
kr677m 23.66%
Unlock
2028
kr702m 3.67%
Unlock

Net Margin

2024 14.21% 112.96%
2025
12.28% 13.61%
Unlock
2026
14.36% 16.94%
Unlock
2027
16.38% 14.07%
Unlock
2028
15.88% 3.05%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share kr 3.79 3.24
113.33% 14.51%
P/E 42.37
EV/Sales 5.49

7 Analysts have issued a Vitrolife forecast for earnings per share. The average Vitrolife EPS is

kr3.24
Unlock
. This is
3.57% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
kr3.60 7.14%
Unlock
, the lowest is
kr2.55 24.11%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 kr3.79 113.33%
2025
kr3.24 14.51%
Unlock
2026
kr4.04 24.69%
Unlock
2027
kr5.00 23.76%
Unlock
2028
kr5.18 3.60%
Unlock

P/E ratio

Current 40.80 549.00%
2025
42.37 3.84%
Unlock
2026
33.92 19.94%
Unlock
2027
27.43 19.13%
Unlock
2028
26.46 3.54%
Unlock

Based on analysts' sales estimates for 2025, the Vitrolife stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.53 45.36%
2025
5.49 0.75%
Unlock
2026
5.14 6.38%
Unlock
2027
4.74 7.77%
Unlock
2028
4.43 6.47%
Unlock

P/S ratio

Current 5.23 46.45%
2025
5.19 0.84%
Unlock
2026
4.86 6.37%
Unlock
2027
4.48 7.77%
Unlock
2028
4.19 6.47%
Unlock

Current Vitrolife Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HANDELSBANKEN CAPITAL MARKETS
Locked
Locked
Locked Jul 21 2025
HANDELSBANKEN CAPITAL MARKETS
Locked
Locked
Locked Jul 02 2025
HANDELSBANKEN CAPITAL MARKETS
Locked
Locked
Locked Jul 01 2025
DNB CARNEGIE
Locked
Locked
Locked Apr 24 2025
DNB CARNEGIE
Locked
Locked
Locked Apr 23 2025
HANDELSBANKEN CAPITAL MARKETS
Locked
Locked
Locked Mar 21 2025
HANDELSBANKEN CAPITAL MARKETS
Locked
Locked
Locked Mar 20 2025
Analyst Rating Date
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
Locked
Jul 21 2025
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
Locked
Jul 02 2025
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
Locked
Jul 01 2025
Locked
DNB CARNEGIE:
Locked
Locked
Apr 24 2025
Locked
DNB CARNEGIE:
Locked
Locked
Apr 23 2025
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
Locked
Mar 21 2025
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
Locked
Mar 20 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today